Aqst Stock Price

( AQST ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment. 46 , which is 73. AQST stock has a five-year performance of %. Stock prices may also move more quickly in this environment. 00 and gave the company a “buy” rating in a report. The all-time high Aquestive Therapeutics stock closing price was 18. This change led market cap to move at 166. (NASDAQ: AQST), a pharmaceutical company focused. No more “Woulda, coulda, shoulda” Access to over 73,400 stock analysis videos. (NASDAQ:AQST) shares traded down 6. 00 , a price to cashflow ratio of 38. 16% below the 52-week high and -49. AQST was a big mover last session, as the company saw its shares rise more than 6% on the day. Fair Value. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. " The 12-month stock price forecast is 15. Any type of moving average can be used to generate buy or sell signals and this process is very simple. Aquestive Therapeutics is selling for under 5. Although wording could have been better in these articles, most of you are using the word "failed" which makes me feel like we need to add the "educated" back into educated investing. Bollinger Bands are 26% narrower than normal. Company Name: Aquestive Therapeutics Inc, Stock Symbol: AQST, Industry: Biotechs, Total Posts: 143, Last Post: 9/29/2020 2:33:04 PM. 28, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. 13, 2018 at 7:22 a. Nine equities research analysts have rated the stock with a buy rating, The company presently has an average rating of Buy and a consensus target price of $14. Get today's Aquestive Therapeutics Inc stock price and latest AQST news as well as Aquestive Therapeutics real-time stock quotes, technical analysis, full financials and more. AQST investment & stock information. Get Aquestive Therapeutics, Inc. Its 52-week range is between 1. AQST Stock Gets $36 Price Target On FDA Accepting NDA. 47 , which gives AQST stock a 52-week price range ratio of 56. Nasdaq 100. Find the latest Aquestive Therapeutics, Inc. Data is currently not available. I'm just glad the folks treating this like a penny stock will be gone on Monday, and I get to buy into AQST at a nice price. The Aquestive Therapeutics 52-week high stock price is 9. Aquestive Therapeutics, Inc. In the last twelve months Aquestive Therapeutics insiders were buying shares, but not selling. (NASDAQ:AQST) shares traded up 7% during trading on Tuesday. Currently, the analyst consensus on Aquestive Therapeutics is a Strong Buy with an average price target of $14. A company's changing earnings picture is at the core of the Zacks rating. The capital turnover (annual revenue relative to shareholder's equity) for AQST is -1. (NASDAQ: AQST) started the day on August 24, 2020, with a price decrease of -3. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. your username. The company traded as high as $7. 96 on September 07, 2018. 72 and last traded at $6. Its stock price blasted past $400 per share around the start of 2020, closing at almost $570 per share earlier this week. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Fair Value. 00, which means current price is +258. Get Aquestive Therapeutics Inc (AQST:NASDAQ) real-time stock quotes, news and financial information from CNBC. AQST has been the subject of a number of analyst reports. I'm just glad the folks treating this like a penny stock will be gone on Monday, and I get to buy into AQST at a nice price. An increase of 151% from the average daily volume of 840,944 shares. Comparativley, The S&P 500 is trading at 1. The company traded as low as $6. Several equities research analysts have commented on AQST shares. The current P/S ratio for Aquestive Therapeutics as of January 19, 2021 is. In layman's terms, the AQST stock price is the highest amount someone is willing to pay for the Aquestive Therapeutics stock, or the lowest amount that it can be bought for. 83, which is a 234. NASDAQ:AQST 😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Our Strategy with this Stock : the company will release the drug for Parkinson disease treatment, The analysts are writing the stock at $17 to drive the sheep to buy the stock , while safe Traders will look for a high price of 6. With a 5-year investment, the revenue is. The company traded as high as $7. Start a 14-day free trial to Morningstar Premium to unlock our take on AQST. This continues the recent uptrend for the company—as the stock is now up 60. ET by Tomi Kilgore Aquestive Therapeutics shares surge 6. The technical evaluation for the stock shows the PEG ratio is 0, with AQST’s current price about -6. AQST's went public 2. AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This is because this security in the Medical - Drugs space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. 25 million of shares of common stock at the public offering price. 00 , a price to cashflow ratio of 38. 00 and gave the company a “buy” rating in a report. 495$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). 00, which means current price is +258. Get the latest Aquestive Therapeutics Inc (AQST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (NASDAQ:AQST) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. 71 at the end of the prior session. and has now fallen 4 days in a row. 51 -- better than just 4. 64 per share, or 34. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term. Aquestive Therapeutics, Inc. candlestick chart analysis, stock chart patterns with Fibonacci retracement lines. The stock had previously closed at $6. HC Wainwright restated a “buy” rating and set a $15. 6/29/2020 7:25:07 AM Aquestive Therapeutics Submits IND For Pharmacokinetic Clinical Trials Of AQST-108 For Anaphylaxis Treatment 2/10/2020 10:15:11 PM ACST Plunges On Data Delay, MREO On Watch, AQST Faces FDA In Sep. According to 6 analysts, the average rating for AQST stock is "Buy. (HBI), Sprouts Farmers Market Inc. The company traded as high as $7. The day’s price range saw the stock hit a low of $6. 9% since reporting last quarter. Aquestive Therapeutics is selling for under 5. According to GuruFocus Insider Data, the recent CFO buys were: Hanesbrands Inc. 00 , a price to cashflow ratio of 38. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Aquestive Therapeutics today and set a price target of $14. Taking a more long-term approach, AQST posted a 52-week range of $1. 7% in the past one-month time frame. For the year, the stock is trading 44. [NASDAQ:AQST] shares were trading 11. Get the latest Aquestive Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Aquestive investment advice, charts, stats and more. "AQST" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market. During that period the price should oscillate between -8. 19 during midday trading on Monday, reaching $5. A number of […]. 60 , a price-to-book (PB) ratio of 14. AQST is down today, but where's it headed in this surging post-election market?. Those same analysts give the stock an average rating of Strong Buy. About Aquestive Therapeutics Inc Aquestive Therapeutics, Inc. 27: Last as of 1/12. The stock traded as high as $5. (HBI): CFO Barry Hytinen bought 10,100 shares. This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. Aquestive Therapeutics Inc (AQST) Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated products to address unmet medical needs. q3 revenue $8. View the real-time AQST price chart on Robinhood and decide if you want to buy or sell commission-free. Investchronicle. Thinking about buying or selling stock in AQST? See the latest Aquestive Therapeutics Inc (AQST) stock analysis, price, forecast, news and more. Aquestive Therapeutics, Inc. Get Aquestive Therapeutics Inc (AQST:NASDAQ) real-time stock quotes, news and financial information from CNBC. This change led market cap to move at 166. RedHill Biopharma Ltd. Aquestive Therapeutics Inc. Aquestive Therapeutics, Inc. Add to Watchlist. Popular Articles. The latest closing stock price for Aquestive Therapeutics as of October 07, 2020 is 4. The move comes after 8 months negative chart setup for the $101. AQST stock forecast Our latest prediction for Aquestive Therapeutics Inc's stock price was made on the Dec. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. AQST Stock Summary. 06: Thursday, 31st Dec 2020 AQST stock ended at $5. Aquestive Therapeutics Inc. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, and Zuplenz. NASDAQ:AQST 😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Our Strategy with this Stock : the company will release the drug for Parkinson disease treatment, The analysts are writing the stock at $17 to drive the sheep to buy the stock , while safe Traders will look for a high price of 6. Aquestive Therapeutics, Inc. Data is currently not available. Tag: AQST stock. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. ( AQST ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment. stock is now -13. Find the latest AQST stock analysis. View which stocks have been most impacted by COVID-19. Would Shareholders Who Purchased Aquestive Therapeutics' (NASDAQ:AQST) Stock Year Be Happy With The Share price Today? Simply Wall St. Thinking about buying or selling stock in AQST? See the latest Aquestive Therapeutics Inc (AQST) stock analysis, price, forecast, news and more. AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. LAST PRICE - 01:10pm AQST is trading DOWN -$-0. Those same analysts give the stock an average rating of Strong Buy. Find the latest Aquestive Therapeutics, Inc. During the day the stock. Lake Street Capital upped their price objective on shares of Aquestive Therapeutics from $7. peers and a company profile. Aquestive Therapeutics, Inc. Right now AQST is $0. 23% down from its year-to-date (YTD) trading value. The company’s 52-week high price is 10. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices. 829,322 shares changed hands during mid-day. Start a 14-day free trial to Morningstar Premium to unlock our take on AQST. The Aquestive Therapeutics Inc. 00 price target. Currently, the analyst consensus on Aquestive Therapeutics is a Strong Buy with an average price target of $14. We do like to see buying, but this purchase was made at well below the current price of US$8. historical stock charts and prices, analyst ratings, financials, and today's real-time AQST stock price. 08% from a day low at $5. Aquestive Therapeutics stock forecast & analyst price target predictions based on 6 analysts offering 12-months price targets for AQST in the last 3 months. Since then, the stock price has increased by 9. 00, which means current price is +258. View daily, weekly or monthly. (NASDAQ:AQST)’s stock price was down 5. Earnings seem to be a alien concept to traders these days. Aquestive Therapeutics, Inc. aqst stock news; aqst price target; See also: Keyword List - Page 141,710. (NASDAQ:AQST) has 0. 05%, respectively, for the quarter ended September 2020. AQST was a big mover last session, as the company saw its shares rise more than 6% on the day. 35 percent down since the beginning of the trading day. 64 per share, or 34. ACST from the largest community of traders and investors. View live AQUESTIVE THERAPEUTICS INC chart to track its stock's price action. 67, the upside potential comes in at 136%. 20 , a PEG ratio of 2. 98 and last traded at $5. historical stock charts and prices, analyst ratings, financials, and today's real-time AQST stock price. Aquestive Therapeutics Stock Price Forecast, AQST stock price prediction. Find real-time AQST - Aquestive Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Historical PS ratio values for Aquestive Therapeutics (AQST) over the last 10 years. Use the Advanced Stock Chart's date range selection to toggle between short term and long term stock price charts for AQST, from one-day to 3-year. AQST Aquestive Therapeutics, Inc. A list of all funds holding AQST. 6/29/2020 7:25:07 AM Aquestive Therapeutics Submits IND For Pharmacokinetic Clinical Trials Of AQST-108 For Anaphylaxis Treatment 2/10/2020 10:15:11 PM ACST Plunges On Data Delay, MREO On Watch, AQST Faces FDA In Sep. View live AQUESTIVE THERAPEUTICS INC chart to track its stock's price action. In layman's terms, the AQST stock price is the highest amount someone is willing to pay for the Aquestive Therapeutics stock, or the lowest amount that it can be bought for. Financial news and investment ideas by TipRanks research team. The latest news and upcoming dividend, earnings, and split events for Aquestive Therapeutics Inc. q3 revenue $8. AQST need to pay close attention to the stock based on moves in the options market lately. 95% Aquestive Therapeutics Inc. Barron's also provides information on historical stock ratings, target prices, company earnings, market. 0 as of 2021-01-20, while the highest AQST forecast in the analyst group was $32. 40 as of the 27th of January 2021; that is -2. stock news by MarketWatch. Find real-time AQST - Aquestive Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Currently, the company is booking earnings per share of -1. Nasdaq 100. AQST stock opened at $5. Aquestive Therapeutics Inc Stock Price Forecast, "AQST" Predictons for2021. (HBI), Sprouts Farmers Market Inc. 39 on Wednesday. February 10, 2020. That average rating earns the stock an Analyst Ranking of 70, w. AQST is UP 4% since the begininning of the year. AQST Stock Price Chart About Aquestive Therapeutics Inc Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated products to address unmet medical needs. 40 and last traded at $7. 39% over the next twelve months. AQST: Get the latest Aquestive Therapeutics stock price and detailed information including AQST news, historical charts and realtime prices. The stock had previously closed at $5. 47 , which gives AQST stock a 52-week price range ratio of 56. Add a live AQST stock price to your free portfolio. The all-time high Aquestive Therapeutics stock closing price was 18. For the year, the stock is trading 44. (AQST) aggregated in real time from around the web on NASDAQ. In the last twelve months Aquestive Therapeutics insiders were buying shares, but not selling. 98 and last traded at $5. your password. 49% from the latest price. The stock had previously closed at $7. 00 , a price to cashflow ratio of 38. Holder Amount Position Size ($ in 1000's) As of; Bratton Capital Management L. AQST is DOWN -2% BELOW 20 day SMA. AQST - Aquestive Therapeutics Inc Stock quote - CNNMoney. The company’s shares closed last Friday at $5. By accessing this page, you agree to the following. 650$ and our data indicates that the. (NASDAQ: AQST), from November 07, 2019 to December 05, 2019 there is a potential. 60 , a price-to-book (PB) ratio of 14. Add a live AQST stock price to your free portfolio. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company). Start a 14-day free trial to Morningstar Premium to unlock our take on AQST. Covered Calls more Stock: Stock Price : Symbol: Expiry: Strike: Premium: Time Value % of Stock : IVol : Months: AQST: 6. The latest closing stock price for Aquestive Therapeutics as of October 07, 2020 is 4. Aquestive Therapeutics stock analysis based on the TipRanks smart score of 8 unique data sets and technical analysis. Approximately 1,249,765 shares traded hands during trading, an increase of 39% from the average daily volume of 900,902 shares. 59 per share on Nov. 1% below the current share price. That average rating earns the stock an Analyst Ranking of 70, w. Approximately 829,322 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 917,411 shares. View daily, weekly or monthly. Several equities research analysts have commented on AQST shares. Dive deeper with interactive charts and top stories of AQUESTIVE THERAPEUTICS, INC. The move comes after 8 months negative chart setup for the $101. 7% in the past one-month time frame. 15 , a price-to-sale (PS) ratio of 4. If you are aware of any facts relating to this investigation, or purchased Aquestive shares, you can assist this investigation by contacting the firm. View AQST stock price today, real time quote with excellent interactive chart, get the latest alerts for Aquestive Therapeutics, Inc, with indicator levels, dividend and earnings details. AQST stock has a five-year performance of %. The move came on solid volume too with far more shares changing hands than in a normal session. This change led market cap to move at 166. On this news, Aquestive’s stock price fell $2. 4% from yesterday's close of $5. This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. View real-time stock prices and stock quotes for a full financial overview. 34 versus $4. Investors in Aquestive Therapeutics, Inc. (NASDAQ:AQST) shares rose 15% on Thursday. 00 , a price to cashflow ratio of 38. 0 as of 2021-01-20, while the highest AQST forecast in the analyst group was $32. The stock's last reported lowest price was 5. AQST investment & stock information. About the Aquestive Therapeutics, Inc. Find real-time AQST - Aquestive Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Historical PS ratio values for Aquestive Therapeutics (AQST) over the last 10 years. 64 per share, or 34. Aquestive Therapeutics Inc. The move came on solid volume too with far more shares changing hands. Using Whois Lookups, What Are They For? A Whois query comes from a. Aquestive Therapeutics stock news, updates & related news. Aquestive Therapeutics, Inc. The company’s stock has a normal trading capacity of 1. View the same stock, ETF, fund or index charted in multiple time-frames to allow for simultaneous short, mid, and long-term analysis of a security. AQST - Aquestive Therapeutics Inc. Aquestive Therapeutics, Inc. The stock's last reported lowest price was 5. View the real-time AQST price chart on Robinhood and decide if you want to buy or sell Why Robinhood? You can buy or sell AQST and other stocks, options, and ETFs commission-free!. A company's changing earnings picture is at the core of the Zacks rating. (NASDAQ: AQST), a pharmaceutical company focused on developing. 31% from a day low at $5. 21 at the close. aqst stock news; aqst price target; See also: Keyword List - Page 141,710. 43% more than the trading day before Thursday, 1st Oct 2020. Aquestive Therapeutics Stock Price Forecast, AQST stock price prediction. 75: EPS next 5Y-ROE-52W Range: Titan Pharmaceuticals Announces Reverse Stock Split. Wainwright analyst Raghuram Selvaraju raised the price target on Aquestive Therapeutics to $15 from $13 and reiterates a Buy rating on the shares. AQST amount got a boost by 7. 495$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). If you are aware of any facts relating to this investigation, or purchased Aquestive shares, you can assist this investigation by contacting the firm. 28, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. aqst stock news; aqst price target; See also: Keyword List - Page 141,710. Stock screener for investors and traders, financial visualizations. The stock decreased 2. 16 in EPS and revenue of $469 million by the end of 2025. Stable Share Price: AQST is not significantly more volatile than the rest of US stocks over the past Share Price vs. 54, while the highest price level was $7. Get Aquestive Therapeutics, Inc. Since then, the stock price has increased by 9. It has underperformed by 4. Would Shareholders Who Purchased Aquestive Therapeutics' (NASDAQ:AQST) Stock Year Be Happy With The Share price. The company has a fifty day moving average price of $6. 25 million of shares of common stock at the public offering price. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term. 39 on Wednesday. 23% down from its year-to-date (YTD) trading value. AQST is down today, but where's it headed in this surging post-election market?. No posts to display. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet. 35%) Post-Market 0. Since then, the stock price has increased by 9. Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to climb 240. Zacks Investment Research lowered Aquestive Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday, January 13th. AQST Stock Summary. Historical PS ratio values for Aquestive Therapeutics (AQST) over the last 10 years. This is not your typical price alert. 46% and +14. 08 and last traded at $5. During the day the stock fluctuated 4. AQST stock quote, chart and news. Get Aquestive Therapeutics Inc (AQST:NASDAQ) real-time stock quotes, news and financial information from CNBC. 67, the upside potential comes in at 136%. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices. 3 Biotech Stocks Under $4 With Big Upside Potential. View the latest Aquestive Therapeutics Inc. (NASDAQ:AQST) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Get the latest Aquestive Therapeutics Inc (AQST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Thinking about buying or selling stock in AQST? See the latest Aquestive Therapeutics Inc (AQST) stock analysis, price, forecast, news and more. 8% upside from current levels. On this news, Aquestive’s stock price fell $2. candlestick chart analysis, stock chart patterns with Fibonacci retracement lines. The price has risen in 6 of the last 10 days and is up by 4. TradingView India. Those same analysts give the stock an average rating of Strong Buy. 4% of US stocks. 37 : AQST: May 21 '21: 5. In a report issued on September 24, Lake Street also maintained a Buy rating on the stock with a $10. The stock had previously closed at $5. Aquestive Therapeutics, Inc. 5% during mid-day trading on Friday. (NASDAQ: AQST), a pharmaceutical company focused on developing. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. (NASDAQ: AQST), from November 07, 2019 to December 05, 2019 there is a potential. According to 6 analysts, the average rating for AQST stock is "Buy. (AQST) aggregated in real time from around the web on NASDAQ. Aquestive Therapeutics, Inc. Aquestive Therapeutics (Aquestive Therapeutics: AQST) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts. Currently Relative Strength Index (RSI-14) reading of stock is 62. Mutual Fund and ETF data. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. The stock traded as high as $5. AQST is DOWN -4% BELOW 200 day SMA. Aquestive Therapeutics stock forecast & analyst price target predictions based on 6 analysts offering 12-months price targets for AQST in the last 3 months. Add to Portfolio. 39% over the next twelve months. For the year, the stock is trading 44. The average Aquestive Therapeutics stock price for the last 52 weeks is 5. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Aquestive Therapeutics, Inc. 06: Thursday, 31st Dec 2020 AQST stock ended at $5. Use the Advanced Stock Chart's date range selection to toggle between short term and long term stock price charts for AQST, from one-day to 3-year. 20 , a PEG ratio of 2. Market capitalization of Aquestive Therapeutics (AQST) Market cap: $0. q3 revenue $8. historical stock charts and prices, analyst ratings, financials, and today's real-time AQST stock price. aqst stock news; aqst price target; See also: Keyword List - Page 141,710. Approximately 829,322 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 917,411 shares. Stock Price » 5. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company). AQST stock has a five-year performance of %. It has underperformed by 4. RedHill Biopharma Ltd. nov 4 (reuters) - aquestive therapeutics inc ::aquestive therapeutics reports third quarter 2020 financial results and provides business update. AQST was a big mover last session, as the company saw its shares rise more than 6% on the day. That is because the Oct 16, 2020 $10. AQST - Aquestive Therapeutics Inc. AQST - Aquestive Therapeutics Inc Stock quote - CNNMoney. I'm just glad the folks treating this like a penny stock will be gone on Monday, and I get to buy into AQST at a nice price. 25 million of shares of common stock at the public offering price. Nov-16-20 08. View real-time stock prices and stock quotes for a full financial overview. 9% since reporting last quarter. Stock analysis for Aquestive Therapeutics Inc (AQST:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. — Stock Price and Discussion | Stocktwits. Approximately 829,322 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 917,411 shares. Related AQST Articles: Interesting AQST Put And Call Options For August 2021 Friday, December 18, 11:31 AM. More articles ». If you are aware of any facts relating to this investigation, or purchased Aquestive shares, you can assist this investigation by contacting the firm. The stock price is performing along up drift from its 200 days moving average with 8. Stable Share Price: AQST is not significantly more volatile than the rest of US stocks over the past Share Price vs. Mutual Fund and ETF data. (NASDAQ:AQST)’s stock price was down 5. Investment news based on TipRanks market leading research tools. Meanwhile, note that the median AQST forecast price target (median being the middle where half of analysts had a higher AQST forecast and half had a lower AQST forecast, which is a different metric than the average or mean) was $14. Get (NASDAQ | AQST Aquestive Therapeutics, Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report. Latest stock price today and the US's most active stock market forums. AQST stock received a price target hike on FDA approval of APL-130277. 0 as of 2021-01-20, while the highest AQST forecast in the analyst group was $32. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing. AQST investment & stock information. your password. Those same analysts give the stock an average rating of Strong Buy. Real-time trade and investing ideas on Acasti Pharma Inc. TradingView India. AQST Stock Summary. Aquestive Therapeutics, Inc. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices. A high-level overview of Aquestive Therapeutics, Inc. A list of all funds holding AQST. Find out if AQST (XNAS) is the best investment for you. Aquestive Therapeutics, Inc. 3 Biotech Stocks Under $4 With Big Upside Potential. Wainwright analyst Raghuram Selvaraju raised the price target on Aquestive Therapeutics to $15 from $13 and reiterates a Buy rating on the shares. By accessing this page, you agree to the following. 50% above the 52-week low. Common Stock (AQST) Nasdaq Listed. Since then, the stock price has increased by 9. 34 versus $4. That is because the Oct 16, 2020 $10. During the day the stock. Use the Advanced Stock Chart's date range selection to toggle between short term and long term stock price charts for AQST, from one-day to 3-year. (AQST) stock price, news, historical charts, analyst ratings and financial information from WSJ. 75 and a two-hundred day moving average price of $6. 53% and -18. Aquestive Therapeutics, Inc. 39% over the next twelve months. Aquestive Therapeutics Inc Stock Price Forecast, "AQST" Predictons for2021. Aquestive Therapeutics, Inc. 29 and last traded at $7. 51 years ago, making it older than only 6. 00% since June 26, 2018 and is. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Aquestive Therapeutics today and set a price target of $14. In the short term (2weeks), AQST's stock price should outperform the market by 3. The average price for this stock is $46 representing 150% upside potential from its current price of $18. AQST Stock saw the intraday high of $5. 7% in the past one-month time frame. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Aquestive Therapeutics today and set a price target of $14. The charting software plots the moving average as a line directly into the price chart. 12 during the last trading session, reaching $4. Stock analysis for Aquestive Therapeutics Inc (AQST:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ( AQST ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment. TradingView India. (NASDAQ:AQST) Short Squeeze Over the past twenty days of trading, Aquestive Therapeutics Inc. AQST is DOWN -2% BELOW 20 day SMA. Those same analysts give the stock an average rating of Strong Buy. Close price at the end of the last trading day (Friday, 2nd Oct 2020) of the AQST stock was $4. Aquestive Therapeutics, Inc. I'm just glad the folks treating this like a penny stock will be gone on Monday, and I get to buy into AQST at a nice price. Based on our forecasts, a long-term increase is expected, the "AQST" stock price prognosis for 2026-01-23 is 14. Range Low Price High Price Comment; 30 days: $5. Headline News. Aquestive Therapeutics (Aquestive Therapeutics: AQST) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts. com is an Economic news website, which offers broad information about the Stock markets and Equities. 43% the S&P500. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. (AQST) stock quote, history, news and other vital information to help you with your stock trading and investing. View AQST stock price today, real time quote with excellent interactive chart, get the latest alerts for Aquestive Therapeutics, Inc, with indicator levels, dividend and earnings details. Aquestive Therapeutics, Inc. ACST from the largest community of traders and investors. (NASDAQ:AQST) shares traded up 7% during trading on Tuesday. Find high and low volatilty options for AQST and other multi-leg option positions for stocks, Stock Stock Price Stock Volume Short Leg Time Value % of Stock Implied. 55% over the past 2 weeks. 46% and +14. 1% below the current share price. 37 : AQST: May 21 '21: 5. 35) is trading below our estimate of fair value. your username. Find out why Aquestive Therapeutics's (AQST) news sentiment is more negative in relation to stocks in the Healthcare sector. In layman's terms, the AQST stock price is the highest amount someone is willing to pay for the Aquestive Therapeutics stock, or the lowest amount that it can be bought for. 39% over the next twelve months. The company report on August 10, 2020 that Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis. Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to climb 240. 39 on Wednesday. (HBI): CFO Barry Hytinen bought 10,100 shares. 55% over the past 2 weeks. Stable Share Price: AQST is not significantly more volatile than the rest of US stocks over the past Share Price vs. "AQST" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market. Get the latest Aquestive Therapeutics, Inc. View the same stock, ETF, fund or index charted in multiple time-frames to allow for simultaneous short, mid, and long-term analysis of a security. More articles ». [NASDAQ:AQST] shares were trading 11. The stock price is performing along up drift from its 200 days moving average with 8. currently has a PE ratio of -4. 65M, putting the price 258. 75 and a two-hundred day moving average price of $6. The stock traded as low as $5. Aquestive Therapeutics is selling for under 5. Aquestive Therapeutics (Aquestive Therapeutics: AQST) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts. During the day the stock fluctuated 4. 39% over the next twelve months. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. Meanwhile, note that the median AQST forecast price target (median being the middle where half of analysts had a higher AQST forecast and half had a lower AQST forecast, which is a different metric than the average or mean) was $14. The all-time high Aquestive Therapeutics stock closing price was 18. Shares are up 11. peers and a company profile. The stock had a trading volume of 1,000,730 shares, compared to its average volume of 879,622. The amount a stock varies from the rest of the market. 20 , a PEG ratio of 2. Real-time trade and investing ideas on Acasti Pharma Inc. No more “Woulda, coulda, shoulda” Access to over 73,400 stock analysis videos. 28, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. The average price for this stock is $46 representing 150% upside potential from its current price of $18. Its stock price has been found in the range of 2. 51 years ago, making it older than only 6. 00% since June 26, 2018 and is. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 67, the upside potential comes in at 136%. Add to Watchlist. 31% from a day low at $5. 59 per share on Nov. (NASDAQ: AQST), from November 07, 2019 to December 05, 2019 there is a potential. The capital turnover (annual revenue relative to shareholder's equity) for AQST is -1. Do the numbers hold clues to what lies ahead for the stock? Wed, Oct 28, 10:33 AM, Zacks. вторник, 17 марта 2020. In the last twelve months Aquestive Therapeutics insiders were buying shares, but not selling. View which stocks have been most impacted by COVID-19. Find the latest AQST stock analysis. (AQST) stock. View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs. US:AQST / Aquestive Therapeutics, Inc. This is because this security in the Medical - Drugs space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. The move came on solid volume too with far more shares changing hands. Interesting AQST Put And Call Options For December 18th Tuesday, October 20, 10:50 AM. 07% and the five-day change stands at 6. 54, while the highest price level was $7. This is compared to its latest closing price of $7. Stock Price » 5. Find out if AQST (XNAS) is the best investment for you. Aquestive Therapeutics, Inc. The stock price is performing along up drift from its 200 days moving average with 8. 820,205 shares changed hands during mid-day trading, a decline of 9% from the average session volume of 900,558 shares. Aquestive Therapeutics, Inc. 83, which is a 234. 495$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Comparativley, The S&P 500 is trading at 1. ET by Tomi Kilgore Aquestive Therapeutics shares surge 6. Social media updates, opinions, and reactions on Aquestive Therapeutics, Inc. Aquestive Therapeutics Inc (AQST) Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics, Inc. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. AQST is UP 4% since the begininning of the year. AQST Stock Quotes API. This is not your typical price alert. Average $15. AQST - Aquestive Therapeutics Inc Stock quote - CNNMoney. Peers 1d 2d 5d 1mo 3mo 6mo 1yr 3yr. AQST - Aquestive Therapeutics Inc. The stock had previously closed at $7. 41 , which is 74. 49% from the latest price. Aquestive Therapeutics Inc. View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs. analyst estimates, including AQST earnings per share estimates and analyst recommendations. 27: Last as of 1/12. By accessing this page, you agree to the following. (AQST) aggregated in real time from around the web on NASDAQ. AQST’s next earning date is 11/10/2020. Aquestive Therapeutics started at outperform with $33 stock price target at Wedbush Sep. Dive deeper with interactive charts and top stories of AQUESTIVE THERAPEUTICS, INC. Those same analysts give the stock an average rating of Strong Buy. 07% and the five-day change stands at 6. Historical PS ratio values for Aquestive Therapeutics (AQST) over the last 10 years. 00 Call had some of the highest implied volatility of all equity options today. AQST is down today, but where's it headed in this surging post-election market?. Aquestive Therapeutics Inc. your password. 7% in the past one-month time frame. AQST is DOWN -2% BELOW 20 day SMA. Aquestive Therapeutics Initiates Phase 1 Pharmacokinetic Trial of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) In Development for Treatment of Allergic Reactions Including. That average rating earns the stock an Analyst Ranking of 70, w. Aquestive Therapeutics (Aquestive Therapeutics: AQST) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts. AQST Stock Price Chart About Aquestive Therapeutics Inc Aquestive Therapeutics is a pharmaceutical company focused on developing and commercializing differentiated products to address unmet medical needs. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address. 60 , a price-to-book (PB) ratio of 14. (AQST) stock. Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to climb 240. (NASDAQ:AQST) shares traded up 7% during trading on Tuesday. See today’s analyst top recommended stocks >>. 40 as of the 27th of January 2021; that is -2. The stock price is performing along up drift from its 200 days moving average with 8. Aquestive Therapeutics, Inc. 9% since reporting last quarter. Aquestive Therapeutics, Inc. (NASDAQ:AQST)’s share price rose 7% on Tuesday. 07% and the five-day change stands at 6. 51 -- better than just 4. AQST | Complete Aquestive Therapeutics Inc. AQST Related ETF s. The average Aquestive Therapeutics stock price for the last 52 weeks is 5. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). During that period the price should oscillate between -8. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Aquestive Therapeutics Inc. AQST - Aquestive Therapeutics Inc. I'm just glad the folks treating this like a penny stock will be gone on Monday, and I get to buy into AQST at a nice price. 31% from a day low at $5. 90M company. 53% and -18. 28, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc.